Company record
McKesson
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about McKesson.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 8 | Class II | McKesson Drug |
Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH, Schiffgraben 23, 38690 Goslar, Germany; Distributed by: Hik⦠Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment. |
| Feb 18 | Class I | McKesson Drug |
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617, NDC 69448-025-63 Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment. |